Xiaodong Li

TOP2A inhibition reverses drug resistance of hepatocellular carcinoma to regorafenib.

Xiaoqun Dong, B. Zhai, Lishan Xu, 2022, American journal of cancer research.

PD-L1 monoclonal antibody-decorated nanoliposomes loaded with Paclitaxel and P-gp transport inhibitor for the synergistic chemotherapy against multidrug resistant gastric cancers

B. Zhai, Jinling Yu, Dongdong Yang, 2020, Nanoscale Research Letters.

Silencing KIF14 reverses acquired resistance to sorafenib in hepatocellular carcinoma

B. Zhai, Lishan Xu, Fengli Hu, 2020, Aging.

The exogenous delivery of microRNA-449b-5p using spermidine-PLGA nanoparticles efficiently decreases hepatic injury

B. Zhai, Dongdong Yang, Fengli Hu, 2019, RSC Advances.

Surgical strategy for gastroesophageal reflux disease in patients with obesity

B. Zhai, Qiankun Zhu, Xiaodong Li, 2020 .

ANXA1 Silencing Increases the Sensitivity of Cancer Cells to Low-concentration Arsenic Trioxide Treatment by Inhibiting ERK MAPK Activation

Lei Zheng, Xueyan Zhang, Lei Lei, 2015, Tumori.